---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001880"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-10-27T23:59:59+00:00"
generated_at: "2026-05-17T02:11:08.935533+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences appoints Mark Spring as CFO effective November 1, 2025

## Summary
- Spring replaces Gregory Gorgas as principal financial officer and treasurer; Gorgas remains CEO.
- Spring receives $250,000 base salary, 35% target bonus, and severance of 12 months base salary (18 months on change in control).
- Gorgas amended agreement: severance increased to 24 months base salary and target bonus (36 months during CIC protection period).
- Gorgas now eligible for severance on constructive termination outside CIC period; vesting provisions revised for post-Effective Date grants.

## SEC filing metadata
- accession: 0001640334-25-001880
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-10-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001880/0001640334-25-001880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001880/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001880
- JSON: https://secwatch.observer/filing/0001640334-25-001880.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.